Reviva Pharmaceuticals Holdings, Inc.
RVPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $59,997 | $122,561 | $82,945 | $42,746 |
| - Cash | $13,476 | $23,367 | $18,520 | $29,688 |
| + Debt | $458 | $0 | $0 | $0 |
| Enterprise Value | $46,979 | $99,193 | $64,425 | $13,058 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$29,881 | -$39,210 | -$24,112 | -$10,105 |
| % Margin | – | – | – | – |
| Net Income | -$29,919 | -$39,261 | -$24,339 | -$8,522 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.9 | -1.65 | -1.45 | -0.58 |
| % Growth | 45.5% | -13.8% | -150% | – |
| Operating Cash Flow | -$33,544 | -$28,324 | -$18,961 | -$10,668 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$33,544 | -$28,324 | -$18,961 | -$10,668 |